Pınar Tığlıoğlu

6PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 14, 2021
The outcome of COVID-19 in patients with hematological malignancy.

Pınar Tığlıoğlu, Murat Albayrak, Mesut Tığlıoğlu

|Aug 23, 2021
Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect.

Mesut Tığlıoğlu, Pınar Tığlıoğlu, Abdulkerim Yıldız

|Apr 13, 2021
Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case.

Hacer Berna Afacan Ozturk, Murat Albayrak, Senem Maral

|Jun 09, 2020
A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis.

Umit Yavuz Malkan, Murat Albayrak, Abdulkerim Yildiz

|Mar 12, 2020
Prognostic Factors in Patients with Low-Grade Nonhodgkin Lymphoma.

Pınar Cömert, Abdulkerim Yıldız, Murat Yıldırım

|Feb 08, 2020
Ibrutinib-induced polyneuropathy: A case report.

Pınar Cömert, Murat Albayrak, Abdulkerim Yıldız

Pageof 1

Frequent Collaborators

5 joint publications

Hacer Berna Öztürk

3 joint publications

Abdulkerim Yıldız

3 joint publications

Senem Maral

3 joint publications

Merih Reis Aras